TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

POZEN Inc. (NASDAQ:POZN) Investor Investigation Concerning Possible Violations of Securities Laws Announced

  • If you purchased shares of POZEN Inc. (NASDAQ:POZN), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

December 26, 2014 (Update) - On December 17, 2014, POZEN Inc announced that its investigational drug candidates YOSPRALA 81/40 and 325/40 received a second complete response letter from the FDA. In this complete response letter, the FDA used identical wording to that of the first complete response letter. Shares of POZEN Inc. (NASDAQ:POZN) declined to as low as $7.62 per share on Dec...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: